Accendra Health Inc.(ACH:US)
Market Cap$20M
Key Metrics
Price$0.26
Revenue (TTM)$2.647B
Holders Revenue (TTM)$8.68M
Gross Profit (TTM)$1.187B
Earnings (TTM)-$302.14M
EBITDA (TTM)$403.15M
Op. Margin (TTM)5.7%
Dividend Yield-
Holders Yield43.39%
Cash on hand$7.65M
Total Assets$2.107B
Net Assets-$550.94M
Total Debt$1.781B
Key Metrics
Price$0.26
Revenue (TTM)$2.647B
Holders Revenue (TTM)$8.68M
Gross Profit (TTM)$1.187B
Earnings (TTM)-$302.14M
EBITDA (TTM)$403.15M
Op. Margin (TTM)5.7%
Dividend Yield-
Holders Yield43.39%
Cash on hand$7.65M
Total Assets$2.107B
Net Assets-$550.94M
Total Debt$1.781B
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
Revenue | $613.23M | $627.78M | $708.97M | $697.26M | $681.92M | $2.632B | $2.696B |
Cost of Revenue | $349.83M | $349.75M | $385.71M | $375.07M | $357.32M | $2.106B | $2.116B |
Gross Profit | $263.41M | $278.03M | $323.26M | $322.2M | $324.6M | $526.01M | $579.77M |
| $243.56M | $255.23M | $271.5M | $265.84M | $267.85M | $464.99M | $484.84M | |
| Research and Development | - | - | - | - | - | - | - |
| Selling, General, and Administrative | $243.56M | $255.23M | $271.5M | $265.84M | $267.85M | $462.35M | $493.07M |
| Other Operating Expenses | - | - | - | - | - | $2.64M | -$8.23M |
Operating Income | $19.85M | $22.8M | $51.76M | $56.36M | $56.75M | $61.02M | $94.93M |
| -$107.48M | -$39.05M | -$59.73M | -$59.99M | -$141.7M | -$96.1M | -$394.58M | |
| Non-Operating Interest Income | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | $34.54M | $32.35M | $27.93M | $29.03M | $26.01M | $33.96M | $35.7M |
| Other Income/Expense | -$72.94M | -$6.7M | -$31.8M | -$30.97M | -$115.69M | -$62.14M | -$358.88M |
Income Before Tax | -$87.63M | -$16.25M | -$7.97M | -$3.64M | -$84.95M | -$35.07M | -$299.65M |
Income Tax | $1.44M | -$9.78M | $1.47M | $1.97M | -$1.13M | -$10.09M | -$3.54M |
Net Income | -$89.07M | -$6.47M | -$56.33M | -$150.28M | -$869.06M | -$24.98M | -$296.12M |
Minority Interests | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - |
Net Income to Common | -$89.07M | -$6.47M | -$56.33M | -$150.28M | -$869.06M | -$24.98M | -$296.12M |
Shares Outstanding (Basic) | 76.7M | 76.43M | 76.7M | 77.29M | 76.94M | 77.27M | 77.17M |
Shares Outstanding (Diluted) | 76.7M | 76.43M | 76.7M | 77.29M | 76.94M | 77.27M | 77.17M |
EPS (Basic) | -$1.16 | -$0.08 | -$0.73 | -$1.94 | -$11.30 | -$0.32 | -$3.84 |
EPS (Diluted) | -$1.16 | -$0.08 | -$0.73 | -$1.94 | -$11.30 | -$0.32 | -$3.84 |
EBIT | -$53.09M | $16.1M | $19.96M | $25.39M | -$58.94M | -$1.12M | -$263.96M |
EBITDA | $84.9M | $83.52M | $80.68M | $154.05M | $133.46M | $120.94M | $159.23M |